A breakdown of the latest mutual funds holding Matinas Biopharma Holdings Inc (MTNB)

In yesterday’s Wall Street session, Matinas Biopharma Holdings Inc (AMEX:MTNB) shares traded at $0.28, down -13.78% from the previous session. As of this writing, 2 analysts cover Matinas Biopharma Holdings Inc (AMEX:MTNB). The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $3.00 […]